Aneel Paulus

1.9k total citations
93 papers, 1.3k citations indexed

About

Aneel Paulus is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Aneel Paulus has authored 93 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Genetics, 34 papers in Hematology and 28 papers in Molecular Biology. Recurrent topics in Aneel Paulus's work include Chronic Lymphocytic Leukemia Research (44 papers), Multiple Myeloma Research and Treatments (31 papers) and Lymphoma Diagnosis and Treatment (18 papers). Aneel Paulus is often cited by papers focused on Chronic Lymphocytic Leukemia Research (44 papers), Multiple Myeloma Research and Treatments (31 papers) and Lymphoma Diagnosis and Treatment (18 papers). Aneel Paulus collaborates with scholars based in United States, Sweden and Italy. Aneel Paulus's co-authors include Asher Chanan‐Khan, Sikander Ailawadhi, Taimur Sher, Kasyapa S. Chitta, Sharoon Akhtar, Abhisek Swaika, Stig Linder, Vivek Roy, Pooja Advani and Thomas R. Caulfield and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Aneel Paulus

88 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aneel Paulus United States 21 611 389 380 310 206 93 1.3k
Barbara Cebula‐Obrzut Poland 21 527 0.9× 304 0.8× 267 0.7× 342 1.1× 218 1.1× 74 1.1k
Elisabet E. Manasanch United States 17 1.2k 1.9× 717 1.8× 721 1.9× 184 0.6× 89 0.4× 108 1.7k
Ehsan Malek United States 15 744 1.2× 538 1.4× 397 1.0× 73 0.2× 78 0.4× 113 1.3k
Shingo Yano Japan 23 478 0.8× 506 1.3× 956 2.5× 349 1.1× 173 0.8× 173 1.9k
Charla Secreto United States 16 561 0.9× 215 0.6× 138 0.4× 475 1.5× 339 1.6× 40 1.3k
Abhisek Swaika United States 15 475 0.8× 549 1.4× 267 0.7× 99 0.3× 155 0.8× 30 1.1k
K. C. Anderson United States 20 670 1.1× 440 1.1× 622 1.6× 206 0.7× 191 0.9× 38 1.6k
Mingjie Li United States 19 583 1.0× 624 1.6× 682 1.8× 109 0.4× 85 0.4× 94 1.4k
Nancy D. Bone United States 20 567 0.9× 319 0.8× 360 0.9× 1.1k 3.5× 764 3.7× 37 1.9k
Tarek H. Mouhieddine United States 18 447 0.7× 457 1.2× 230 0.6× 92 0.3× 111 0.5× 61 1.2k

Countries citing papers authored by Aneel Paulus

Since Specialization
Citations

This map shows the geographic impact of Aneel Paulus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aneel Paulus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aneel Paulus more than expected).

Fields of papers citing papers by Aneel Paulus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aneel Paulus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aneel Paulus. The network helps show where Aneel Paulus may publish in the future.

Co-authorship network of co-authors of Aneel Paulus

This figure shows the co-authorship network connecting the top 25 collaborators of Aneel Paulus. A scholar is included among the top collaborators of Aneel Paulus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aneel Paulus. Aneel Paulus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moinuddin, Irfan, et al.. (2025). Conversion of Tacrolimus to Cyclosporine or Low-Dose Belatacept for Refractory BK Virus Kidney Transplant Nephropathy. American Journal of Transplantation. 25(8). S625–S625.
2.
Ailawadhi, Sikander, Ricardo Parrondo, Vivek Roy, et al.. (2023). The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers. Cancer Medicine. 12(18). 19013–19020. 2 indexed citations
3.
Paulus, Aneel, Fabio Malavasi, & Asher Chanan‐Khan. (2022). CD38 as a multifaceted immunotherapeutic target in CLL. Leukemia & lymphoma. 63(10). 2265–2275. 5 indexed citations
4.
Madamsetty, Vijay Sagar, Aneel Paulus, Sharoon Akhtar, et al.. (2020). Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia. Leukemia & lymphoma. 61(10). 2399–2408. 4 indexed citations
5.
Iqbal, Madiha, Aaron Spaulding, Shehzad K. Niazi, et al.. (2020). Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation Recipients. Psychosomatics. 61(4). 363–370. 1 indexed citations
6.
Kumar, Vivek, Chander Shekher Aggarwal, Vivek Roy, et al.. (2020). Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis. Clinical Lymphoma Myeloma & Leukemia. 21(5). e449–e455. 22 indexed citations
7.
Kumar, Vivek, Sikander Ailawadhi, Aditya Mehta, et al.. (2019). Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia. Blood Cancer Journal. 9(10). 75–75. 44 indexed citations
8.
Manna, Alak, Salman Ahmed, Sharoon Akhtar, et al.. (2019). Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 25(13). 3974–3985. 31 indexed citations
9.
Advani, Pooja, Aneel Paulus, & Sikander Ailawadhi. (2019). Updates in prognostication and treatment of Waldenström's macroglobulinemia. Hematology/Oncology and Stem Cell Therapy. 12(4). 179–188. 4 indexed citations
10.
Rosenfeld, Steven S., Alfredo Quiñones‐Hinojosa, Aneel Paulus, et al.. (2019). Survival trends in glioblastoma and association with treating facility volume. Journal of Clinical Neuroscience. 68. 271–274. 16 indexed citations
11.
Laali, Kenneth K., Frederick J. Troendle, Gabriela L. Borosky, et al.. (2018). Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity. ChemMedChem. 13(18). 1895–1908. 14 indexed citations
12.
Schiapparelli, Paula, Alak Manna, Aneel Paulus, et al.. (2018). CD38 Targeted Therapy in Glioblastoma: A Step Forward. (P4.160). Neurology. 90(15_supplement). 1 indexed citations
13.
14.
15.
Wang, Xin, Magdalena Mazurkiewicz, Ellin‐Kristina Hillert, et al.. (2016). The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells. Scientific Reports. 6(1). 26979–26979. 133 indexed citations
16.
Paulus, Aneel, Kasyapa S. Chitta, Paul K. Wallace, et al.. (2015). Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications. PLoS ONE. 10(4). e0122338–e0122338. 11 indexed citations
17.
Chitta, Kasyapa S., Aneel Paulus, Thomas R. Caulfield, et al.. (2014). Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia. Blood Cancer Journal. 4(11). e260–e260. 26 indexed citations
18.
19.
Moulin, M. F. M. T. Du, et al.. (2007). Effects of Introducing a Specialized Nurse in the Care of Community-Dwelling Women Suffering From Urinary Incontinence. Journal of Wound Ostomy and Continence Nursing. 34(6). 631–640. 13 indexed citations
20.
Heusch, Andreas, et al.. (1997). Anomalous Origin of All Coronary Arteries from the Pulmonary Trunk. Cardiology. 88(6). 603–608. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Cebula‐Obrzut Breakdown of academic impact, for papers by Elisabet E. Manasanch Breakdown of academic impact, for papers by Ehsan Malek Breakdown of academic impact, for papers by Shingo Yano Breakdown of academic impact, for papers by Charla Secreto Breakdown of academic impact, for papers by Abhisek Swaika Breakdown of academic impact, for papers by K. C. Anderson Breakdown of academic impact, for papers by Mingjie Li Breakdown of academic impact, for papers by Nancy D. Bone Breakdown of academic impact, for papers by Tarek H. Mouhieddine
Rankless by CCL
2026